TaiGen Biopharmaceuticals Holdings Ltd (太景醫藥研發控股) on Wednesday said that it is venturing into the North American market through its partnership with Luminarie Canada Inc, which would develop and commercialize its antibiotic Taigexyn in Canada.
Luminarie would also help develop the drug in Australia and New Zealand, TaiGen said, after the two companies signed an exclusive licensing agreement, with Luminarie to assume all associated costs for the antibiotic’s development.
In exchange for the exclusive rights, Luminarie is to pay TaiGen milestone payments upon the achievement of the following: Luminarie’s application for marketing approval, application for a manufacturing drug license, obtaining marketing approval, obtaining a license and setting the drug price under the healthcare insurance system, TaiGen said.
Photo: Chen Yung-chi, Taipei Times
Luminarie would purchase Taigexyn at a pre-negotiated price from TaiGen for its commercialization, it said.
TaiGen did not reveal how much the milestone payments would be, or when its Canadian partner plans to apply for regulatory approvals in the three markets.
TaiGen also licensed Luminarie to seek another company that would commercialize Taigexyn in the US, to leverage the Canadian pharmaceutical company’s network in North America, it said.
“We are interested in Luminarie because we share the same innovative vision for Taigexyn,” TaiGen chairman Philip Huang (黃國龍) said in a statement. “By partnering with Luminarie, TaiGen would be able to tap into these developed markets where the need for such a novel antibiotic to treat drug-resistant infection is very high.”
The company’s business strategy is to work with foreign partners to expand into overseas markets, as they have stronger connections in the pharmaceutical environment abroad and better familiarity with regulations, a TaiGen official told the Taipei Times by telephone yesterday.
Through the partnership with Luminarie, TaiGen has expanded the drug into 35 markets, including Taiwan and China, said the official, who declined to be named.
Taigexyn is a safe and effective antibiotic for the treatment of bacterial infections, including those caused by drug-resistant bacteria, the company said.
TaiGen reported a cumulative revenue of NT$13.96 million (US$479,297) in the first eight months of the year, up 17.4 percent from a year earlier, as some doctors used Taigexyn to treat COVID-19 patients who also had bacterial infections, it said.
Quanta Computer Inc (廣達) chairman Barry Lam (林百里) is expected to share his views about the artificial intelligence (AI) industry’s prospects during his speech at the company’s 37th anniversary ceremony, as AI servers have become a new growth engine for the equipment manufacturing service provider. Lam’s speech is much anticipated, as Quanta has risen as one of the world’s major AI server suppliers. The company reported a 30 percent year-on-year growth in consolidated revenue to NT$1.41 trillion (US$43.35 billion) last year, thanks to fast-growing demand for servers, especially those with AI capabilities. The company told investors in November last year that
United Microelectronics Corp (UMC, 聯電) forecast that its wafer shipments this quarter would grow up to 7 percent sequentially and the factory utilization rate would rise to 75 percent, indicating that customers did not alter their ordering behavior due to the US President Donald Trump’s capricious US tariff policies. However, the uncertainty about US tariffs has weighed on the chipmaker’s business visibility for the second half of this year, UMC chief financial officer Liu Chi-tung (劉啟東) said at an online earnings conference yesterday. “Although the escalating trade tensions and global tariff policies have increased uncertainty in the semiconductor industry, we have not
Intel Corp has named Tasha Chuang (莊蓓瑜) to lead Intel Taiwan in a bid to reinforce relations between the company and its Taiwanese partners. The appointment of Chuang as general manager for Intel Taiwan takes effect on Thursday, the firm said in a statement yesterday. Chuang is to lead her team in Taiwan to pursue product development and sales growth in an effort to reinforce the company’s ties with its partners and clients, Intel said. Chuang was previously in charge of managing Intel’s ties with leading Taiwanese PC brand Asustek Computer Inc (華碩), which included helping Asustek strengthen its global businesses, the company
Power supply and electronic components maker Delta Electronics Inc (台達電) yesterday said it plans to ship its new 1 megawatt charging systems for electric trucks and buses in the first half of next year at the earliest. The new charging piles, which deliver up to 1 megawatt of charging power, are designed for heavy-duty electric vehicles, and support a maximum current of 1,500 amperes and output of 1,250 volts, Delta said in a news release. “If everything goes smoothly, we could begin shipping those new charging systems as early as in the first half of next year,” a company official said. The new
RSS